Histone deacetylase inhibition attenuates diabetes-associated kidney growth: potential role for epigenetic modification of the epidermal growth factor receptor
about
Histone Acetylation and Its Modifiers in the Pathogenesis of Diabetic NephropathyEGFR signaling in renal fibrosisEvidence for the involvement of epigenetics in the progression of renal fibrogenesisFluorescent microangiography is a novel and widely applicable technique for delineating the renal microvasculatureMicroRNA-29a promotion of nephrin acetylation ameliorates hyperglycemia-induced podocyte dysfunction.HDAC4 blocks autophagy to trigger podocyte injury: non-epigenetic action in diabetic nephropathy.Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signalingTreatment of chronic kidney diseases with histone deacetylase inhibitors.Recent developments in epigenetics of acute and chronic kidney diseases.Angiotensin-(1-7) inhibits epidermal growth factor receptor transactivation via a Mas receptor-dependent pathway.Hyperglycemia and renal mass ablation synergistically augment albuminuria in the diabetic subtotally nephrectomized rat: implications for modeling diabetic nephropathyMetabolic memory and chronic diabetes complications: potential role for epigenetic mechanisms.Role of epidermal growth factor receptor in acute and chronic kidney injury.eNOS deficiency predisposes podocytes to injury in diabetes.HDAC inhibitors in experimental liver and kidney fibrosis.Histone Deacetylase-3/CAGE Axis Targets EGFR Signaling and Regulates the Response to Anti-Cancer DrugsRapid Identification of Potential Drugs for Diabetic Nephropathy Using Whole-Genome Expression Profiles of Glomeruli.Impact of high glucose and proteasome inhibitor MG132 on histone H2A and H2B ubiquitination in rat glomerular mesangial cells.A potential adjuvant chemotherapeutics, 18β-glycyrrhetinic acid, inhibits renal tubular epithelial cells apoptosis via enhancing BMP-7 epigenetically through targeting HDAC2.Histone deacetylase inhibitor enhances recovery after AKI.The Histone Methyltransferase Enzyme Enhancer of Zeste Homolog 2 Protects against Podocyte Oxidative Stress and Renal Injury in Diabetes.HDAC inhibitors in kidney development and disease.Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney.Trichostatin A suppresses EGFR expression through induction of microRNA-7 in an HDAC-independent manner in lapatinib-treated cells.Why do anti-inflammatory therapies fail to improve insulin sensitivity?Histone lysine methylation in diabetic nephropathy.The next generation of therapeutics for chronic kidney diseaseEpigenetics of kidney disease.Role of Epigenetic Histone Modifications in Diabetic Kidney Disease Involving Renal Fibrosis.Histone Adduction and Its Functional Impact on EpigeneticsGreater efficacy of atorvastatin versus a non-statin lipid-lowering agent against renal injury: potential role as a histone deacetylase inhibitor.A look at transactivation of the EGF receptor by angiotensin II.Autophagy in diabetic kidney disease: regulation, pathological role and therapeutic potential.Emerging Evidence of Epigenetic Modifications in Vascular Complication of Diabetes.Histone deacetylase 2 is involved in µ‑opioid receptor suppression in the spinal dorsal horn in a rat model of chronic pancreatitis pain.Therapeutic effects of histone deacetylase inhibitors on kidney disease.HDAC6 Inhibition Promotes Transcription Factor EB Activation and Is Protective in Experimental Kidney Disease.Histone deacetylase inhibitors protect against cisplatin-induced acute kidney injury by activating autophagy in proximal tubular cells.Histone Deacetylase Inhibitors and Diabetic Kidney Disease
P2860
Q26744442-1750B082-1AD2-469B-B370-A1DE8712E755Q26796628-EE1664A3-7544-4BFC-AC10-B9C3A57AB91BQ26827293-1DA0F35F-568E-4A2F-BA78-4B3E66288FBBQ27320632-7ED1719F-F4A1-4300-A626-0766A15A8EE7Q33974555-CCA81D97-9938-45D8-BB37-326292294571Q34273008-9D587336-85A7-44A8-BA95-F0CD3BDE61CDQ34559028-98DB45D3-977C-4937-B319-CE96E973E55AQ35545347-6CBCA121-61E1-4824-B8CB-76780E05133BQ35909055-8274EFAC-EF30-49A0-A4FB-8B0E119882FBQ36024889-DA35B262-F5F8-4AF3-8745-2DF555DFD571Q36058792-83A4F37E-A5D5-4D3E-9633-E3A1CD714E7FQ36205231-F68D4A6B-07E7-447F-BE97-C8C215ECCD29Q36224457-9994BE49-96EF-4941-A019-87F572C65431Q36352132-6D5C5EFE-561C-4577-B2F0-684E20577674Q36588493-D1F3B3E1-6D16-478D-950F-E85BF47E17A7Q36693836-90EC8126-65F1-42AF-A573-0539D51DC0B7Q36741213-1B593F44-2274-4BB3-B09A-9764CDEF5C2EQ36853565-4AB73E33-40B6-49B2-AF17-B1413C993C4FQ36870776-C7DE86FC-290B-430D-8424-203762509C4FQ36880455-EB7796D3-F46D-4F5E-A954-684383C39F51Q37051959-B5B1F75B-59B5-45FC-816D-C38BD2ADE6BAQ37115414-BBC70D43-0A33-4BDB-8B73-704856E7B2DBQ37253944-37BFF8A9-0172-467A-A12F-6C0C3CBE791DQ37632279-2242AE8C-8460-4DE2-A067-912054D549EFQ37950733-60593869-CD4A-4C16-BD47-F2D79BB56ECAQ38248614-9672EF51-698B-4E2E-9870-3FBB95E392E0Q38845590-137A660A-B88E-41A3-91CD-098F190CB1D8Q39175636-5DCC4AB0-DE5F-44CB-BAC2-95E5E9CC96B8Q39427404-A2704CE4-5DBC-4D0F-9F2C-3A7C3C340F03Q42024732-BA0B7FDD-0480-46B7-BBC8-9972343AFFFFQ42361500-53487C55-0F7B-468E-A333-C76FE3A306BDQ43066733-6FFC03A0-E929-4E92-9DEF-5208D486735DQ46312225-769D1801-8ED1-4024-A1EB-12D1CD5A1EA1Q47159412-70C676CF-8D8B-42C0-A0FE-A1DA2A06DF48Q47906679-149DFD47-2A6D-4F5D-89DC-DCB7B1D8822AQ48136812-D1F21AC1-2608-45FF-A8C3-1A5D033A90EEQ49620168-B35D33E8-9D19-4C23-B1BC-349D2078DE8AQ54988474-0D88F091-8BE1-47D5-931B-A926A5F141E7Q58762435-B44D66B8-672C-46C0-A7D1-D86B712FC136
P2860
Histone deacetylase inhibition attenuates diabetes-associated kidney growth: potential role for epigenetic modification of the epidermal growth factor receptor
description
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2011
@ast
im Juni 2011 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2011/06/01)
@sk
vědecký článek publikovaný v roce 2011
@cs
wetenschappelijk artikel (gepubliceerd op 2011/06/01)
@nl
наукова стаття, опублікована в червні 2011
@uk
مقالة علمية (نشرت في يونيو 2011)
@ar
name
Histone deacetylase inhibition ...... idermal growth factor receptor
@ast
Histone deacetylase inhibition ...... idermal growth factor receptor
@en
Histone deacetylase inhibition ...... idermal growth factor receptor
@nl
type
label
Histone deacetylase inhibition ...... idermal growth factor receptor
@ast
Histone deacetylase inhibition ...... idermal growth factor receptor
@en
Histone deacetylase inhibition ...... idermal growth factor receptor
@nl
prefLabel
Histone deacetylase inhibition ...... idermal growth factor receptor
@ast
Histone deacetylase inhibition ...... idermal growth factor receptor
@en
Histone deacetylase inhibition ...... idermal growth factor receptor
@nl
P2093
P3181
P356
P1433
P1476
Histone deacetylase inhibition ...... idermal growth factor receptor
@en
P2093
Andrew Advani
Darren A. Yuen
Kerri Thai
Kim A. Connelly
Qingling Huang
Richard E. Gilbert
Suzanne L. Advani
P2888
P304
P3181
P356
10.1038/KI.2011.39
P407
P577
2011-06-01T00:00:00Z
P6179
1002790475